Ask your healthcare provider about switching to a different GLP-1 or a different weight loss medication that may be less expensive or covered by your health insurance plan
As mentioned, these side effects are due to food staying in the stomach longer as a result of delayed digestion and gastric emptying
No evidence of severe endocrine, cardiovascular, or hepatic adverse effects has been observed in available research data
Some natural skin contraction occurs after weight loss, particularly in younger patients with good baseline skin elasticity
Compared to the uninfected snails, transcripts encoding distinct proteases are highly downregulated in infected snails, while those encoding heat-shock proteins and actins are significantly upregulated (353)
Once weekly Injection Frequency 45 to 90 Needle Insertion Angle 3 sites Approved Injection Zones Investigational compound: Retatrutide (LY3437943) has not received FDA approval as of June 2026